DAVID R. GUYER

Insider Reports History

Location
New York, NY
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAVID R. GUYER:

Company Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 1,850 $18,619 $10.06 12 Jul 2024 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 6,525 12 Jul 2024 Direct

Insider Reports Filed by DAVID R. GUYER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EYPT EyePoint Pharmaceuticals, Inc. 12 Jul 2024 5 -$84,349 4 Director 16 Jul 2024, 16:24
EYPT EyePoint Pharmaceuticals, Inc. 03 Jun 2024 5 -$87,058 4 Director 04 Jun 2024, 16:28
EYPT EyePoint Pharmaceuticals, Inc. 14 May 2024 5 -$114,398 4 Director 16 May 2024, 17:19
EYPT EyePoint Pharmaceuticals, Inc. 05 Jan 2024 1 $0 4 Director 09 Jan 2024, 20:56
EYPT EyePoint Pharmaceuticals, Inc. 20 Jun 2023 2 $0 4 Director 22 Jun 2023, 09:22
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2023 2 $0 4 Director 13 Feb 2023, 16:08
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2022 4 $0 4 Director 11 Feb 2022, 15:54
EYPT EyePoint Pharmaceuticals, Inc. 22 Jun 2021 2 $0 4 Director 23 Jun 2021, 17:30